13F Insight

Schilke Tobin

CIK: 0001678984•Chief Financial Officer
Officer
Primary company: Revance Therapeutics, Inc. (RVNC)
Total Transactions
79
Total Buy Value
$0
Total Sell Value
$2.17M
Net Activity
$-2.17M
Last Transaction
Mar 2025
Companies
3

Companies

Transaction History